It will presently be launched in the New Jersey and all other State Legislatures. It is further planned to make this definitely comprehensive and effective by Federal legislation, already drafted and soon to be introduced at Washington. Charles B. Towns, its author, also wrote the law, already on the statute books of New York and several other States, permitting the sale of the hypodermic syringe only upon prescription by a doctor; he presented last year at Albany a comprehensive bill which did not pass. His measure of this year, known in the Senate as the Boylan bill, includes many features new to legislation of the sort, and has already won outspoken approval from many members of the medical profession, including Dr. Alexander Lambert of New York, and Dr. Richard C. Cabot of Boston. Commissioner Davis has gone over it with care, indorsing it. “To wholly control the drug evil, which is so unfortunately affecting New York City and the State, by any legislation entirely local to the State,” said Mr. Towns, “is out of the question. But a beginning must be made at home. “For various reasons habit-forming drugs have found a stronger foothold in this country than elsewhere in the world. Our annual opium consumption, per capita, is far greater than that of China, although we use it principally in the form of its derivatives, morphine, etc., and our consumption of cocaine has grown to a magnitude unprecedented anywhere. “Most of the legislation drafted for the purpose of restricting the use of habit-forming drugs has been ineffective. It is ridiculously easy to-day to obtain morphine or any other of the inhibited substances in New York without violation of the law, although New York has laws which were designed to be of drastic force. “The classification in my bill reads: ‘Opium, morphia, coca leaves, cocaine, alpha and beta cocaine, their salts, derivatives and preparations.’ “This classification includes automatically many substances which it does not specifically mention, but which have recently attracted much attention because of their common use among drug-habitues. “Among these is heroin. But heroin is a derivative of morphine, which is the active principle of opium, and is three times as strong as the parent drug. “It is not mentioned in the bill because the word ‘heroin’ is a mere trade name, and a law prohibiting its sale under that name would not prohibit the sale of the same substance under any one of the new trade names which manufacturers would have no difficulty in coining. “I speak of this almost at once, because I have had several inquiries as to why this drug apparently is omitted from the list named in the bill.